We hypothesized that, according to the STRING‐PPI network and literature review, DNM2 is needed for the endocytosis of various proteins involved in tumor motility and invasiveness and for endocytosis of various oncogenic receptors, including the epidermal growth factor receptor (EGFR) [53], ErbB2 [54], and platelet‐derived growth factor receptor (PDGFR) [55]. This evidence concerns the gene DNM2 and neoplasm.